Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - HK
$ 441.5
-7.69 %
$ 5.75 B
Market Cap
-1296.87
P/E
RGC - NET INCOME
Net Income RGC - Regencell Bioscience Holdings Limited
-4.36 M
LAST VALUE
24.20%
2 YEAR CAGR
-62.00%
5 YEAR CAGR
-0.27%
10 YEAR CAGR